[144] BOSTON SCIENTIFIC CORP SEC Filing

Rhea-AI Filing Summary

Boston Scientific (BSX) insider Joseph M. Fitzgerald filed a Form 144 indicating an intended sale of 50,000 shares of common stock, with an aggregate market value $4,973,335. The sales are planned for approximately 11/03/2025 on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services.

The shares were acquired via stock option exercise on 11/03/2025 for cash. As context, 1,482,442,039 shares were outstanding. Over the past three months, Fitzgerald sold 50,000 shares on 10/01/2025 for $4,923,325 and 50,000 shares on 09/02/2025 for $5,271,415.

Insights

Securities law analyst

Routine Form 144 notice for planned secondary sales.

Form 144 notifies potential sales by an affiliate under Rule 144. Here, Joseph M. Fitzgerald lists a planned sale of 50,000 shares of Boston Scientific common stock, with an $4,973,335 aggregate market value and an approximate sale date of 11/03/2025. The broker is Morgan Stanley Smith Barney LLC Executive Financial Services and the venue is the NYSE.

The filing states the shares were acquired via stock option exercise on 11/03/2025 for cash. The excerpt also lists prior three-month sales: 50,000 shares on 10/01/2025 for $4,923,325 and 50,000 on 09/02/2025 for $5,271,415. Shares outstanding were 1,482,442,039, a baseline figure disclosed by the issuer.

Actual sales and timing depend on market conditions and Rule 144 parameters. Subsequent filings may provide execution details if sales occur.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	4973335.00	1482442039	11/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/03/2025	Stock Option Exercise	ISSUER			50000	11/03/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOSEPH M FITZGERALD 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234	Common	10/01/2025	50000	4923325.00
JOSEPH M FITZGERALD 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234	Common	09/02/2025	50000	5271415.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Boston Scientific (BSX)’s Form 144 disclose?

A planned sale of 50,000 common shares with an aggregate market value $4,973,335, approximately on 11/03/2025 via the NYSE.

Who is the selling affiliate in BSX’s Form 144 and how were shares acquired?

The filer is Joseph M. Fitzgerald, who acquired the shares via stock option exercise on 11/03/2025 for cash.

Which broker and exchange are listed for the BSX planned sale?

Broker: Morgan Stanley Smith Barney LLC Executive Financial Services; Exchange: NYSE.

How many Boston Scientific shares were outstanding as disclosed?

Shares outstanding were 1,482,442,039.

What sales did the filer make in the past three months?

50,000 shares on 10/01/2025 for $4,923,325 and 50,000 shares on 09/02/2025 for $5,271,415.

What is the class of securities in the BSX Form 144?

The filing relates to common stock.